Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Szymendera

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Diseases of the Colon and Rectum|January 1, 1982
Predictive value of plasma CEA levels: preoperative prognosis and postoperative monitoring of patients with colorectal carcinomaJ J Szymendera, M P Nowacki, A W Szawłowski, et al.
Oncology|January 1, 1983
Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumorsJ J Szymendera, J Zborzil, L Sikorowa, et al.
Gynecologic Oncology|February 1, 1986
Gestational trophoblastic diseases: the ratio of choriogonadotropin to specific pregnancy protein, hCG/SP1, provides useful diagnostic and prognostic evidenceJ J Szymendera, E Ploch, K Zalucka, et al.
Oncology|January 1, 1985
Clinical usefulness of serum ferritin measurements in patients with testicular germ cell tumorsJ J Szymendera, I Kozłowicz-Gudzinska, G Madej, et al.
Diseases of the Colon and Rectum|April 1, 1982
Serial CEA assays and liver scintigraphy for the detection of hepatic metastases from colorectal carcinomaJ J Szymendera, J E Wilczyńska, M P Nowacki, et al.
The International Journal of Biological Markers|January 1, 1987
Serum levels of carcinoembryonic antigen, gastrointestinal cancer-associated antigen and alphafetoprotein in staging and management of patients with advanced carcinoma of the stomachJ J Szymendera, A W Szawlowski, M P Nowacki, et al.
Nowotwory|July 1, 1990
[Identification of a limited form of small cell lung cancer among 103 patients pre-selected for chemotherapy combined with surgery]T Lewiński, M Zuławski, O Mioduszewska, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1989
Pretreatment concentrations of breast carcinoma antigen (CA 15.3) and mucin-like carcinoma-associated antigen in patients with carcinoma of the breastS S Góźdź, M M Kowalska, J T Słuszniak, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1993
Serum CA-15.3 and CEA patterns in postsurgical follow-up, and in monitoring clinical course of metastatic cancer in patients with breast carcinomaM A al-Jarallah, A E Behbehani, S A el-Nass, et al.
The International Journal of Biological Markers|July 1, 1988
Carcinoembryonic antigen and breast carcinoma antigen (CA 15.3) in preoperative staging and postoperative monitoring of patients with carcinoma of the breastY T Omar, A E Behbehani, N al-Naqeeb, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Diseases of the Colon and Rectum|January 1, 1982
Predictive value of plasma CEA levels: preoperative prognosis and postoperative monitoring of patients with colorectal carcinomaJ J Szymendera, M P Nowacki, A W Szawłowski, et al.
Oncology|January 1, 1983
Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumorsJ J Szymendera, J Zborzil, L Sikorowa, et al.
Gynecologic Oncology|February 1, 1986
Gestational trophoblastic diseases: the ratio of choriogonadotropin to specific pregnancy protein, hCG/SP1, provides useful diagnostic and prognostic evidenceJ J Szymendera, E Ploch, K Zalucka, et al.
Oncology|January 1, 1985
Clinical usefulness of serum ferritin measurements in patients with testicular germ cell tumorsJ J Szymendera, I Kozłowicz-Gudzinska, G Madej, et al.
Diseases of the Colon and Rectum|April 1, 1982
Serial CEA assays and liver scintigraphy for the detection of hepatic metastases from colorectal carcinomaJ J Szymendera, J E Wilczyńska, M P Nowacki, et al.
The International Journal of Biological Markers|January 1, 1987
Serum levels of carcinoembryonic antigen, gastrointestinal cancer-associated antigen and alphafetoprotein in staging and management of patients with advanced carcinoma of the stomachJ J Szymendera, A W Szawlowski, M P Nowacki, et al.
Nowotwory|July 1, 1990
[Identification of a limited form of small cell lung cancer among 103 patients pre-selected for chemotherapy combined with surgery]T Lewiński, M Zuławski, O Mioduszewska, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1989
Pretreatment concentrations of breast carcinoma antigen (CA 15.3) and mucin-like carcinoma-associated antigen in patients with carcinoma of the breastS S Góźdź, M M Kowalska, J T Słuszniak, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1993
Serum CA-15.3 and CEA patterns in postsurgical follow-up, and in monitoring clinical course of metastatic cancer in patients with breast carcinomaM A al-Jarallah, A E Behbehani, S A el-Nass, et al.
The International Journal of Biological Markers|July 1, 1988
Carcinoembryonic antigen and breast carcinoma antigen (CA 15.3) in preoperative staging and postoperative monitoring of patients with carcinoma of the breastY T Omar, A E Behbehani, N al-Naqeeb, et al.
Pageof 3